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Abstract
Subjects: Cases are two patients with type 1 diabetes mellitus 
(T1DM), with the characteristic relationship and onset situation. Case 
1 is 46-year-old daughter and case 2 is 69-year-old mother. They have 
been living apart and they rarely meet together. Twenty-two months 
after the onset of T1DM case 1, case 2 also developed T1DM. They did 
not notice clinical manifestation of upper respiratory infection, or they 
did not have any stressful matters before the onset of T1DM. 
Results: Their data in case 1 vs 2 were as follows: BMI 21.3 vs 19.8, 
HbA1c 10.3% vs 9.8%, anti-IA-2 antibody (IA-2 Ab) 2.1 vs 6.0 (<0.4), 
anti-GAD antibody (GAD Ab) 24 vs 10000 (<1.5), HLA-DR type DR9 / 
DR13 vs DR4/DR13.
Discussion and conclusion: These 2 cases have characteristic 
mode for the onset of T1DM. In Japanese race, DR4 and DR9 have rather 
high sensitivity for T1DM, DR15 (DR2) has resistance for T1DM and 
DR13 has unremarkable influence. From these, HLA-DR type would be 
possible involved in the onset of T1DM, and further investigation would 
be expected.
Keywords: Type 1 diabetes mellitus (T1DM), Anti-IA-2 antibody, Anti-
GAD antibody, HLA-DR type.
Abbreviations: Type 1 Diabetes Mellitus (T1DM); Tyrosine 
Phosphatase-related Islet Antigen 2 (IA-2 Ab), Anti-glutamic Acid 
Decarboxylase Antibody (GAD Ab), Human Leukocyte Antigen (HLA).
Introduction
In Type 1 diabetes mellitus (T1DM) has been one of the common 
autoimmune disorders. Its pathophysiological mechanism is the 
immunological destruction of the β cells of the pancreas. It will cause the 
dysregulation of glucose variability and metabolism. T1DM has reported 
having family cluster associated with an overall genetic risk [1-3].
Furthermore, the association analysis of HLA loci has shown the 
presence of T1DM susceptibility [4]. In order to proceed with the 
research of T1DM genes, an international collaboration this is the Type 
1 Diabetes Genetics Consortium, has continued to evaluate lots of T1DM 
families from various countries [5]. For related predisposition of T1DM, 
there were some findings that combination of HLAA24, -DQA1*03, and 
-DR9 could contribute to the acute-onset and early destruction in the 
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β cells of the pancreas, and that HLA-DR2 has a protective 
effect in contrast [6].
Moreover, susceptible, neutral, and protective DR-
DQ haplotypes for T1DM risk have been identified in the 
analyses of Caucasian and Asian families [7]. The most 
susceptible haplotypes are the DRB1*0301-DQA1*0501-
DQB1*0201 and the DRB1*0405-DQA1*0301-DQB1*0302, 
DRB1*0401-DQA1*0301-DQB*0302, and DRB1*0402-
DQA1*0301-DQB1*0302 haplotypes. Thus, DR4 has been 
frequently involved in the risk.
As related matters with mentioned above, we have 
experienced two cases of acute onset of T1DM which are 
daughter and mother. These clinically impressive cases are 
presented in this report.
Case presentation
Case 1 is 46-year-old female who has been working in 
regular daily life, without any remarkable disease or health 
problem in the past. She developed acute symptoms of general 
malaise and weight reduction for 5 kg. She was diagnosed to 
have diabetes in another clinic, and was transferred to our 
clinic for further evaluation and treatment of diabetes.
As basal data, her physical was normal, such as vitals, 
heart, lung, abdomen and neurological findings. Her Body 
Mass Index (BMI) was 21.3 kg/m2. Laboratory examination 
on routine revealed as follows: HbA1c 10.3%, glucose 277 
mg/dL, Hb 12.9 g/dL, WBC 5100/µL, Plt 19.5 × 10 V/µL, AST 
16 IU/mL, ALT 18 IU/mL, r-GT 15 IU/mL, TP 6.7 mg/dL, 
BUN 19 mg/dL, Cre 0.5 mg/dL, Uric Acid 3.2 mg/dL, HDL 82 
mg/dL, LDL 95 mg/dL, TG 37 mg/dL. Blood C-peptide <0.1 
ng/mL, CRP 0.0 mg/dL.
For adequate diabetic treatment of T1DM, she was 
started insulin therapy, using short-acting and long-acting 
insulin. It was successfully performed and several months 
later HbA1c was maintained 7.2-7.5%.
Case 2 is the mother of case 1. She is 69-year-old female 
who has not to have any positive previous medical history or 
family history. She has been staying at home in regular daily 
life without any remarkable health problems. She has not 
worked in a certain company, but just continued growing 
some crops in her home vegetable garden for 2-3 hours a 
day. About 22 months after case 1 became diabetic, she 
developed rather acute weight reduction. She was diagnosed 
to have T1DM. She visited our diabetic clinic and was given 
further evaluation and treatment for diabetes.
As basal data, her physicals showed unremarkable 
changes such as vitals, heart, lung, abdomen and neurological 
findings. Her body mass index (BMI) was 19.8 kg/m2. 
Laboratory examination on routine revealed as follows: 
HbA1c 9.8%, glucose 386 mg/dL, Hb 13.3 g/dL, WBC 5200 
/µL, Plt 17.4 × 10 V/µL, AST 22 IU/mL, ALT 21 IU/mL, r-GT 
17 IU/mL, TP 7.7 mg/dL, BUN 14 mg/dL, Cre 0.6 mg/dL, Uric 
Acid 3.3 mg/dL, HDL 68 mg/dL, LDL 99 mg/dL, TG 67 mg/
dL. Blood C-peptide <0.1 ng/mL, CRP 0.2 mg/dL, CEA 3.4 ng/
mL, TSH 0.4 µU/mL, free T4 1.12 ng/mL.
For her generalized condition as T1DM, she was started 
to have insulin therapy, including two times of 30 R insulin 
injections a day. The clinical course revealed efficacy for 
insulin therapy, and several months later HbA1c was 
maintained 6.5%-6.8%.
The comparison of the data obtained from case 1 and 2 
was summarized in Table 1. It showed the differences in the 
value of antibodies and the type of HLA-DR.
Discussion
In this report, two cases are clinically rare and 
meaningful. Case 1 and 2 were daughter and mother with 46 
and 69 years old, who had the onset of T1DM in 22 months 
apart. They do not live together and rarely meet, and neither 
have any prodromal symptoms such as upper respiratory 
infection before the onset. There are no exposures or special 
episodes suggestive of stress to the mind and body. As 
described above, they were unlikely to have common causes 
for the onset.
Originally, the relationship between genetic factors and 
environmental factors has been pointed out with regard to 
the onset of disease. The environmental factors have usually 
influenced by 95% and genetic factors are 5%, in ordinary 
diseases [2]. In these two cases, it seems that there are no 
common items in environmental factors, with the possible 
involvement of the genetic factors.
Candidate genes reported to be associated with T1DM 
include Human Leukocyte Antigen (HLA), Insulin (INS), 
Protein Tyrosine Phosphatase Non-receptor Type 22 (PTPN 
22), and Small Ubiquitin-like Modifier (SUMO). Among them, 
HLA has polymorphisms of DR and DQ, and it is said that 
human locus is involved in locus IDDM1 on chromosome 
6p21 [1].
Several reports on the relationship between T1DM and 
HLA were found. Generally, in the case of T1DM in Japanese, 
data showed susceptible to DR4, DR9, resistant to DR15 
(DR2), and unremarkable effect on DR 13 [6].
There has been familial clustering of T1DM, in which 
about 40-50% of them are involved in the influence of 
allelic variation in the HLA region [8]. Other studies showed 
that specific alleles at the DRB1, DQA1, and DQB1 loci are 
strongly responsible for T1DM [9].
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Table 1: comparison of case 1 and 2.
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experts. Informed consent and written consent were 
obtained from the subjects.
The authors would like to appreciate the patients and 
staffs for their continuous cooperation and support. The 
authors declare that there are no conflicts of interest.
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Concerning Asian-specific HLA haplotypes on 
susceptibility to T1DM, Japanese and Korean patients were 
studied [10]. The results were that DRB1*0405-DQB1*0401 
and DRB1*0901-DQB1*0303 were confirmed to be two major 
susceptible HLA haplotypes in the Japanese population [10].
According to the analysis of the HLA-DR and DQ 
haplotypes in Japanese adult-onset T1DM [11]. There 
were two major susceptible HLA haplotypes, which were 
DRB1*0405-DQB1*0401 (DR4) and DRB1*0901-DQB1*0303 
(DR9). They were significantly increased in the acute-onset 
type 1 diabetic patients (AO) and childhood-onset type 1 
diabetes (CO) groups, but only DR9 was increased in the 
slowly progressive type 1 diabetic patients (SO) group [11].
After that, serological subtypes were determined in 
3 groups [12]. They are i) normal subjects, ii) typical 
autoimmune T1DM, and iii) fulminant T1DM which 
characterized by acute onset and an absence of islet-related 
auto antibodies, account for 20% of T1DM in Japan. As the 
result, ii) DR9 but not DR4 was more frequent and DR2 was 
extremely rare, iii) DR4, but not DR9, was significantly more 
frequent, while DR1, DR2, DR5 and DR8 were significantly 
lower than controls [12]. From these, susceptibility and 
resistance of the HLA subtype to T1DM are distinct between 
ii) and iii).
In the case of Finland study, there was the study of HLA 
genes predisposing effect of T1DM [13,14]. The result was 
that The DRB1*0401-DQB1*0302 haplotype was the most 
prevalent disease susceptibility haplotype in the Finnish 
[13,14]. Thus, DRB1*0401 has been involved in the T1DM in 
Japan and also European country.
Conclusion
In this report, 2 familial cases of T1DM whose onset were 
46 and 69 years old with similar clinical manifestation. HLA 
analyses showed that they have DR 4 and DR 9, suggesting 
these would be two major susceptible HLA to influence 
the onset of T1DM in Japan. Further evaluation would be 
expected for clarification of detail involvement mechanism 
in future research.
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